Enanta Pharmaceuticals, Inc.
corporate_fare Company Profile
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ENTA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Enanta Pharmaceuticals Seeks Shareholder Approval for Significant Equity Plan Expansion
Financial Snapshot
Fiscal year ended September 30, 2026
Revenue
$63M
Net Income
-$68.25M
Diluted EPS
-$2.35
Op. Cash Flow
-$42.56M
Free Cash Flow
-$42.77M
Operating Income
-$62.38M
Cash & Equivalents
$20.27M
Debt / Equity
0.00×
Net Margin
-108.3%
Shares Outstanding
29.14M sh
Source: 10-K · filed 2026-11-18 · accession 0001193125-26-466170
show_chartPrice Chart
Loading chart...
feed ENTA - Filings & News (Page 2)
ENTA
Jan 26, 2026, 4:05 PM EST
Price at Filing:
$12.92
Real-time Price:
$7.62
Change:
-$5.30 (-41%)
Market Cap:
$222.19M